VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
259 hedge funds and large institutions have $4.58B invested in Verona Pharma in 2025 Q1 according to their latest regulatory filings, with 86 funds opening new positions, 71 increasing their positions, 87 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.93% more ownership
Funds ownership: 10.48% → 11.41% (+0.93%)
18% less repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 87
51% less call options, than puts
Call options by funds: $70.5M | Put options by funds: $144M
Holders
259
Holding in Top 10
28
Calls
$70.5M
Puts
$144M
Top Buyers
| 1 | +$241M | |
| 2 | +$195M | |
| 3 | +$86.8M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$82.1M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$68.9M |
Top Sellers
| 1 | -$184M | |
| 2 | -$85.4M | |
| 3 | -$82.1M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$64.1M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$56.7M |